Loading: 100%
Merck & Co., Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter Whitehouse Station, United States of AmericaWhitehouse Station, United States of Americano data available
Employees 68,000 (as per Q1 2017)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker MRKno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 1755,0057,7560,5063,2566,00
datesClosing price (adj.)
13.10.201763.39
11.10.201763.78
04.10.201764.60
27.09.201764.57
20.09.201765.79
13.09.201764.99
06.09.201763.55
30.08.201762.67
23.08.201761.71
16.08.201762.26
09.08.201762.05
02.08.201762.99
26.07.201761.36
19.07.201762.18
12.07.201762.34
05.07.201763.71
27.06.201765.08
20.06.201764.07
13.06.201762.82
06.06.201763.74
30.05.201763.95
23.05.201763.62
16.05.201762.87
09.05.201762.38
02.05.201761.80
25.04.201761.40
18.04.201761.37
11.04.201761.68
04.04.201762.75
28.03.201762.43
21.03.201762.99
14.03.201763.28
07.03.201764.54
28.02.201764.45
21.02.201764.07
14.02.201764.25
07.02.201762.82
31.01.201760.65
24.01.201759.89
17.01.201760.16
10.01.201758.63
03.01.201758.85
27.12.201658.50
19.12.201659.82
12.12.201659.93
05.12.201658.51
28.11.201660.01
21.11.201660.50
14.11.201661.69
07.11.201658.31
31.10.201657.02
24.10.201658.99
17.10.201659.74
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
63.39n/a
Market Capitalisation
in million USD
173,382n/a
Enterprise Value
in million USD
185,678n/a
Common Shares Outstanding
as per Apr 30, 2017
2,735,164,510n/a
Preferred Shares Outstanding
as per Apr 30, 2017
n/a
Average Basic Shares Outstanding
TTM
2,758,750,000n/a
Average Diluted Shares Outstanding
TTM
2,779,750,000n/a
Index Membership
n/a
Business Summary
Merck & Co Inc is a health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 39,907n/a
Gross Profit 25,498n/a
Operating Income 8,441n/a
EBITDA 14,287n/a
Net Profit 5,491n/a
Balance Sheet
Cash and Cash Equivalents 13,060n/a
Receivables 7,364n/a
Total Current Assets 29,433n/a
PP&E 12,029n/a
Total Assets 98,328n/a
Accounts Payable 2,481n/a
Current Debt 1,487n/a
Total Current Liabilities 15,555n/a
Long-Term Debt 23,656n/a
Total Liabilities 54,378n/a
Total Equity 43,957n/a
Cash Flow
Depreciation & Amortisation 5,846n/a
Change in Working Capital -2,483n/a
Operating Cash Flow 10,991n/a
Net Change in PP&E and Intangibles -1,556n/a
Investing Cash Flow -1,264n/a
Dividends Paid -5,116n/a
Financing Cash Flow -9,474n/a
Total Change in Cash 359n/a
Free Cash Flow 8,927n/a
Profitability Ratios
Gross Margin 63.9%n/a
Operating Margin 21.2%n/a
Net Profit Margin 13.8%n/a
Return on Equity 12.5%n/a
Return on Assets 5.6%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA 13.00n/a
EV/Sales 4.65n/a
Book to Market Value 0.25n/a
Other Ratios
Current Ratio 189.2%n/a
Liabilities to Equity Ratio 123.7%n/a
Debt to Assets Ratio 25.6%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Revenue
24,198
23,850
27,428
45,987
48,047
47,267
44,033
42,237
39,498
Sales & Services Revenue
0
0
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
0
0
Cost of revenue
-6,141
-5,583
-9,019
-18,396
-16,871
-16,446
-16,954
-16,768
-14,934
Cost of Goods & Services
0
0
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
0
0
Gross Profit
18,057
18,267
18,409
27,591
31,176
30,821
27,079
25,469
24,564
Other Operating Income
0
0
0
0
0
0
0
0
0
Operating Expenses
-12,440
-12,182
-14,388
-24,236
-22,200
-20,944
-19,414
-18,786
-17,017
Selling, General & Administrative
-7,557
-7,377
-8,543
-13,125
-13,733
-12,776
-11,911
-11,606
-10,313
Selling & Marketing
0
0
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
0
0
Research & Development
-4,883
-4,805
-5,845
-11,111
-8,467
-8,168
-7,503
-7,180
-6,704
Depreciation & Amortization
0
0
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
0
0
Operating Income (Loss)
5,618
6,085
4,021
3,355
8,976
9,877
7,665
6,683
7,547
Non-Operating Income (Loss)
3,052
4,879
12,903
-717
-336
-474
-411
11,613
-1,527
Interest Expense, net
0
0
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates
2,977
2,561
2,235
587
610
642
0
0
0
Other Non-Operating Income (Loss)
75
2,318
10,668
-1,304
-946
-1,116
-411
11,613
-1,527
Pretax Income (Loss), Adjusted
8,669
10,964
16,924
2,638
8,640
9,403
7,254
18,296
6,020
Abnormal Gains (Losses)
-5,177
-1,033
-1,634
-985
-1,306
-664
-1,709
-1,013
-619
Acquired In-Process R&D
0
0
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
0
0
Pretax Income (Loss)
3,492
9,931
15,290
1,653
7,334
8,739
5,545
17,283
5,401
Income Tax (Expense) Benefit, net
-95
-1,999
-2,268
-671
-942
-2,440
-1,028
-5,349
-942
Current Income Tax
0
0
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
3,397
7,932
13,022
982
6,392
6,299
4,517
11,934
4,459
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
3,397
7,932
13,022
982
6,392
6,299
4,517
11,934
4,459
Minority Interest
-121
-124
-123
-121
-120
-131
-113
-14
-17
Net Income
3,275
7,808
12,899
861
6,272
6,168
4,404
11,920
4,442
Preferred Dividends
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
3,275
7,808
12,899
861
6,272
6,168
4,404
11,920
4,442
Remarks
restated on Mar 1, 2010 n/a
calculated values,
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 28, 2017 n/a
calculated values,
Balance SheetBS data quality: 97% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
5,486
9,604
12,201
14,972
16,141
17,486
15,719
13,427
Cash & Cash Equivalents
n/a
4,368
9,311
10,900
13,531
13,451
15,621
7,441
8,524
Short Term Investments
n/a
1,118
293
1,301
1,441
2,690
1,865
8,278
4,903
Accounts & Notes Receivable
n/a
2,908
6,603
7,344
8,261
7,672
7,184
6,626
6,484
Accounts Receivable, Net
n/a
2,908
6,603
7,344
8,261
7,672
7,184
6,626
6,484
Notes Receivable, Net
n/a
0
0
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
0
0
Inventories
n/a
2,091
8,048
5,868
6,254
6,535
6,226
5,571
4,700
Raw Materials
n/a
0
0
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
0
0
Other Short Term Assets
n/a
8,628
4,177
3,651
3,694
4,509
4,789
4,689
5,140
Prepaid Expenses
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
8,628
4,177
3,651
3,694
4,509
4,789
4,689
5,140
Total Current Assets
n/a
19,113
28,432
29,064
33,181
34,857
35,685
32,605
29,751
Property, Plant & Equipment, Net
n/a
12,000
18,279
17,082
16,297
16,030
14,973
13,136
12,507
Property, Plant & Equipment
n/a
24,128
30,874
30,563
32,473
33,415
33,094
31,140
0
Accumulated Depreciation
n/a
-12,129
-12,595
-13,481
-16,176
-17,385
-18,121
-18,004
0
Long Term Investments & Receivables
n/a
6,491
432
2,175
3,458
7,305
9,770
13,515
13,039
Long Term Investments
n/a
0
0
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
0
0
Other Long Term Assets
n/a
9,592
65,171
57,460
52,192
47,940
45,217
38,911
46,380
Intangible Assets
n/a
0
0
0
0
0
0
0
0
Goodwill
n/a
1,439
12,038
12,378
12,155
12,134
12,301
12,992
17,723
Other Intangible Assets
n/a
525
47,757
39,456
34,302
29,083
23,801
20,386
22,602
Prepaid Expense
n/a
0
0
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
7,628
5,376
5,626
5,735
6,723
9,115
5,533
6,055
Total Noncurrent Assets
n/a
28,083
83,882
76,717
71,947
71,275
69,960
65,562
71,926
Total Assets
n/a
47,196
112,314
105,781
105,128
106,132
105,645
98,167
101,677
Liabilities and owners' equity
Payables & Accruals
n/a
2,848 2847500000
4,600 4600000000
4,727 4727000000
4,085 4085000000
4,296 4296000000
3,846 3846000000
5,170 5170000000
5,402 5402000000
Accounts Payable
n/a
618 617600000
2,244 2244000000
2,308 2308000000
2,023 2023000000
1,753 1753000000
2,274 2274000000
2,625 2625000000
2,533 2533000000
Accrued Taxes
n/a
1,426 1426400000
1,167 1167000000
1,243 1243000000
781 781000000
1,200 1200000000
251 251000000
1,237 1237000000
1,560 1560000000
Interest & Dividends Payable
n/a
804 803500000
1,189 1189000000
1,176 1176000000
1,281 1281000000
1,343 1343000000
1,321 1321000000
1,308 1308000000
1,309 1309000000
Other Payables & Accruals
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Debt
n/a
2,297 2297100000
1,379 1379000000
2,400 2400000000
1,990 1990000000
4,315 4315000000
4,521 4521000000
2,704 2704000000
2,583 2583000000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
9,174 9174100000
9,455 9455000000
8,514 8514000000
10,170 10170000000
9,737 9737000000
9,501 9501000000
10,523 10523000000
11,216 11216000000
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
9,174 9174100000
9,455 9455000000
8,514 8514000000
10,170 10170000000
9,737 9737000000
9,501 9501000000
10,523 10523000000
11,216 11216000000
Total Current Liabilities
n/a
14,319 14318700000
15,434 15434000000
15,641 15641000000
16,245 16245000000
18,348 18348000000
17,868 17868000000
18,397 18397000000
19,201 19201000000
Long Term Debt
n/a
3,943 3943300000
16,095 16095000000
15,482 15482000000
15,525 15525000000
16,254 16254000000
20,539 20539000000
18,699 18699000000
23,829 23829000000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
7,767 7766600000
19,093 19093000000
17,853 17853000000
16,415 16415000000
16,067 16067000000
14,912 14912000000
12,280 12280000000
13,880 13880000000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
7,767 7766600000
19,093 19093000000
17,853 17853000000
16,415 16415000000
5,740 5740000000
6,776 6776000000
4,467 4467000000
6,535 6535000000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
0 0
0 0
0 0
0 0
10,327 10327000000
8,136 8136000000
7,813 7813000000
7,345 7345000000
Total Noncurrent Liabilities
n/a
11,710 11709900000
35,188 35188000000
33,335 33335000000
31,940 31940000000
32,321 32321000000
35,451 35451000000
30,979 30979000000
37,709 37709000000
Total Liabilities
n/a
26,029 26028600000
50,622 50622000000
48,976 48976000000
48,185 48185000000
50,669 50669000000
53,319 53319000000
49,376 49376000000
56,910 56910000000
Preferred Equity
n/a
0 0
207 207000000
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
8,349 8348900000
41,464 41464000000
42,489 42489000000
42,451 42451000000
42,434 42434000000
42,296 42296000000
42,211 42211000000
42,010 42010000000
Common Stock
n/a
30 29800000
1,781 1781000000
1,788 1788000000
1,788 1788000000
1,788 1788000000
1,788 1788000000
1,788 1788000000
1,788 1788000000
Additional Paid in Capital
n/a
8,319 8319100000
39,683 39683000000
40,701 40701000000
40,663 40663000000
40,646 40646000000
40,508 40508000000
40,423 40423000000
40,222 40222000000
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
-30,736 -30735500000
-21,044 -21044000000
-22,433 -22433000000
-23,792 -23792000000
-24,717 -24717000000
-29,591 -29591000000
-35,262 -35262000000
-38,534 -38534000000
Retained Earnings
n/a
43,699 43698800000
41,405 41405000000
37,536 37536000000
38,990 38990000000
39,985 39985000000
39,257 39257000000
46,021 46021000000
45,348 45348000000
Other Equity
n/a
-2,554 -2553900000
-2,767 -2767000000
-3,216 -3216000000
-3,132 -3132000000
-4,682 -4682000000
-2,197 -2197000000
-4,323 -4323000000
-4,148 -4148000000
Equity Before Minority Interest
n/a
18,758 18758300000
59,265 59265000000
54,376 54376000000
54,517 54517000000
53,020 53020000000
49,765 49765000000
48,647 48647000000
44,676 44676000000
Minority Interest
n/a
2,409 2408800000
2,427 2427000000
2,429 2429000000
2,426 2426000000
2,443 2443000000
2,561 2561000000
144 144000000
91 91000000
Total Equity
n/a
21,167 21167100000
61,692 61692000000
56,805 56805000000
56,943 56943000000
55,463 55463000000
52,326 52326000000
48,791 48791000000
44,767 44767000000
Total Liabilities & Equity
n/a
47,196 47195700000
112,314 112314000000
105,781 105781000000
105,128 105128000000
106,132 106132000000
105,645 105645000000
98,167 98167000000
101,677 101677000000
Remarks restated on n/a restated on Mar 1, 2010 n/a restated on Feb 28, 2011 n/a restated on Feb 28, 2012 n/a restated on Feb 28, 2013 n/a restated on Feb 27, 2014 n/a restated on Feb 27, 2015 n/a restated on Feb 26, 2016 n/a restated on Aug 8, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '07FY '08FY '09FY '10FY '11FY '12FY '13FY '14FY '15
Net Income/Starting Line
3,397
7,932
13,022
982
6,392
6,299
4,517
11,934
4,459
Net Income
0
0
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
0
0
Depreciation & Amortization
1,988
1,631
2,576
7,381
7,427
6,978
6,988
6,691
6,375
Non-Cash Items
258
992
-9,503
1,529
-670
881
943
-12,589
1,855
Stock-Based Compensation
0
0
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
0
0
Change in Working Capital
1,356
-3,983
-2,703
930
-766
-4,136
-794
1,824
-268
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
0
0
Cash from Operating Activities
6,999
6,572
3,392
10,822
12,383
10,022
11,654
7,860
12,421
Change in Fixed Assets & Intangibles
-1,011
-1,298
-1,461
-1,678
-1,723
-1,954
-1,548
-2,317
-1,283
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
0
0
Net Change in Long Term Investment
728
-901
7,871
-2,636
-1,176
-5,058
-1,693
-9,830
3,732
Decrease in Long Term Investment
0
0
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
-1,136
1,899
3,870
391
125
0
-200
-2,293
-7,428
Net Cash from Divestitures
0
0
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
0
0
Other Investing Activities
-1,391
-1,534
-7,124
426
-116
207
293
14,066
221
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
0
0
Cash from Investing Activities
-2,810
-1,834
3,156
-3,497
-2,890
-6,805
-3,148
-374
-4,758
Dividends Paid
-3,307
-3,279
-3,215
-4,734
-4,691
-5,116
-5,157
-5,170
-5,117
Cash From (Repayment of) Debt
-1,184
468
1,781
748
-471
3,164
4,533
-3,931
3,492
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-531
-2,623
186
-1,230
-1,600
-1,281
-5,306
-6,143
-3,701
Increase in Capital Stock
0
0
0
0
0
0
0
0
0
Decrease in Capital Stock
0
0
0
0
0
0
0
0
0
Other Financing Activities
156
-89
-390
-225
-142
-34
-60
131
56
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
-4,866
-5,523
-1,638
-5,441
-6,904
-3,267
-5,990
-15,113
-5,270
Net Cash Before Disc. Operations and FX
-677
-785
4,910
1,884
2,589
-50
2,516
-7,627
2,393
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
0
0
Net Cash Before FX
-677
-785
4,910
1,884
2,589
-50
2,516
-7,627
2,393
Effect of Foreign Exchange Rates
98
-183
33
-295
42
-30
-346
-553
-1,310
Net Changes in Cash
-579
-968
4,943
1,589
2,631
-80
2,170
-8,180
1,083
Remarks
restated on Mar 1, 2010 n/a
calculated values,
restated on Feb 28, 2011 n/a
calculated values,
restated on Feb 28, 2012 n/a
calculated values,
restated on Feb 28, 2013 n/a
calculated values,
restated on Feb 27, 2014 n/a
calculated values,
restated on Feb 27, 2015 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Feb 26, 2016 n/a
calculated values,
restated on Nov 30, -1 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo